Comparaison of Avatar Therapy to Cognitive Behavioral Therapy in Schizophrenia With Treatment Refractory Hallucinations (Phase3)
A Randomized Controlled Trial Comparing Avatar Therapy to Cognitive Behavioral Therapy in Schizophrenia With Treatment Refractory Hallucinations
Sponsor: Canadian Institutes of Health Research (CIHR)
Listed as NCT04054778, this NA trial focuses on Auditory Hallucination, Verbal and Treatment-resistant Schizophrenia and remains ongoing. Sponsored by Canadian Institutes of Health Research (CIHR), it has been updated 10 times since 2019, reflecting substantial change activity. Mental health research at this phase helps define safety and dosing parameters for future study.
Status Flow
Change History
10 versions recorded-
Mar 2026 — Present [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2025 — Mar 2026 [monthly]
Recruiting NA
-
Sep 2024 — Sep 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Mar 2024 — Jul 2024 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Dec 2022 — Mar 2024 [monthly]
Recruiting NA
-
Sep 2021 — Dec 2022 [monthly]
Recruiting NA
-
Jan 2021 — Sep 2021 [monthly]
Recruiting NA
-
Nov 2019 — Jan 2021 [monthly]
Recruiting NA
-
Sep 2019 — Nov 2019 [monthly]
Recruiting NA
First recorded
Apr 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Canadian Institutes of Health Research (CIHR)
- Ciusss de L'Est de l'Île de Montréal
For direct contact, visit the study record on ClinicalTrials.gov .